6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1)
Names
[ CAS No. ]:
59709-57-8
[ Name ]:
6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1)
[Synonym ]:
1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol,hydrobromide
MFCD00012741
Chemical & Physical Properties
[ Boiling Point ]:
362.6ºC at 760 mmHg
[ Melting Point ]:
186-187ºC(lit.)
[ Molecular Formula ]:
C10H14BrNO2
[ Molecular Weight ]:
260.12800
[ Flash Point ]:
175.4ºC
[ Exact Mass ]:
259.02100
[ PSA ]:
52.49000
[ LogP ]:
2.59140
[ Appearance of Characters ]:
white to brown
[ Storage condition ]:
Hygroscopic, -20?C Freezer, Under Inert Atmosphere
[ Stability ]:
Store in freezer at -20°C
[ Water Solubility ]:
H2O: soluble5mg/mL (warmed; clear solution)
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
R34
[ Safety Phrases ]:
S25-S36/37/39-S45
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2933499090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2933499090
[ Summary ]:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
J. Appl. Toxicol. 35(2) , 219-27, (2014)
Unforeseen toxic effects contribute to compound attrition during preclinical evaluation and clinical trials. Consequently, there is a need to correlate in vitro toxicity to in vivo and clinical outcom...